Barhemsys

Product manufactured by Acacia Pharma Ltd

Application Nr Approved Date Route Status External Links
NDA209510 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Barhemsys ® Is Indicated In Adults For: Prevention Of Postoperative Nausea And Vomiting (Ponv), Either Alone Or In Combination With An Antiemetic Of A Different Class. Treatment Of Ponv In Patients Who Have Received Antiemetic Prophylaxis With An Agent Of A Different Class Or Have Not Received Prophylaxis. Barhemsys Is A Dopamine-2 (D 2 ) Antagonist Indicated In Adults For: Prevention Of Postoperative Nausea And Vomiting (Ponv), Either Alone Or In Combination With An Antiemetic Of A Different Class. ( 1 ) Treatment Of Ponv In Patients Who Have Received Antiemetic Prophylaxis With An Agent Of A Different Class Or Have Not Received Prophylaxis. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Amisulpride AMISULPRIDE ZINC601255

Comments